HMPV

Clinical trials for HMPV explained in plain language.

Never miss a new study

Get alerted when new HMPV trials appear

Sign up with your email to follow new studies for HMPV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

One shot, two viruses: new vaccine targets RSV and hMPV in seniors

⭐️ VACCINE ⭐️ Completed

This early-stage trial tested a new vaccine designed to protect against both RSV and hMPV, two common respiratory viruses. 385 healthy adults aged 60 to 75 received a single injection of different doses. The main goals were to check safety and measure the immune response. Results…

Matched conditions: HMPV

Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️

Last updated Jun 27, 2026 07:59 UTC

HMPV

Get alerted when new HMPV trials appear

One shot, two viruses: new vaccine targets RSV and hMPV in seniors